IL6 and breast carcinoma: In addition to the vasculature, this putative connection between IL-6 and PI3KαH1047R raises implications for paracrine crosstalk with resident immune, adipocyte, and mesenchymal cells that advances breast cancer progression in patients harboring PI3Kα activating mutations61,62.